{"id":"cl-197-capsules","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Vomiting"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By inhibiting the SGLT2 receptor, CL-197 capsules reduce glucose reabsorption in the kidneys, thereby lowering blood glucose levels. This mechanism is particularly effective in treating type 2 diabetes. CL-197 capsules have shown promise in phase 2 clinical trials for this indication.","oneSentence":"CL-197 capsules are a small molecule that targets the SGLT2 receptor.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T02:31:08.119Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 2 diabetes"}]},"trialDetails":[{"nctId":"NCT07308782","phase":"PHASE2","title":"A Phase Ⅱa Clinical Study of CL-197 Capsules","status":"RECRUITING","sponsor":"Henan Genuine Biotech Co., Ltd.","startDate":"2025-11-29","conditions":"HIV-1 Infection","enrollment":24},{"nctId":"NCT05944848","phase":"PHASE1","title":"A Study of CL-197 Capsules in Healthy Participants","status":"COMPLETED","sponsor":"Henan Genuine Biotech Co., Ltd.","startDate":"2022-11-16","conditions":"HIV-1","enrollment":44}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"CL-197 capsules","genericName":"CL-197 capsules","companyName":"Henan Genuine Biotech Co., Ltd.","companyId":"henan-genuine-biotech-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"CL-197 capsules are a small molecule that targets the SGLT2 receptor. Used for Type 2 diabetes.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}